Question 1

What does peer-reviewed research say about these claims?

Accepted Answer

Bro translation: Mainstream medical consensus does not support the use of urine neurotransmitter testing to diagnose psychiatric conditions like ADD/ADHD, depression, or anxiety; these tests lack diagnostic validity and are not recommended by major psychiatric guidelines. Similarly, stool analysis is not a validated diagnostic tool for systemic diseases like diabetes, autoimmune disorders, or cardiovascular disease, and IgG food sensitivity testing is not supported for diagnosing chronic health issues like eczema or asthma. The claim that DNA-based programs provide the 'only' diet and exercise recommendations needed is also unsupported by evidence, as genetic predisposition does not override the fundamental principles of nutrition and exercise.

Question 2

Are Josselson's credentials legitimate?

Accepted Answer

Melissa Josselson, ND, uses a narrow naturopathic license to claim broad diagnostic authority for serious psychiatric (ADD/ADHD, depression) and systemic (autoimmune, diabetes) conditions, a classic case of credential inflation. Stated credentials: ND, DR, DOCTOR. Likely credentials: unverified. Credential inflation detected, a white coat is not the same as an MD/DO license.

Question 3

Is Dr Josselson a real medical doctor?

Accepted Answer

Josselson is not identified as an MD/DO physician in reviewed credentials or public registry data. Likely credential: Naturopath (ND).

Question 4

Does Josselson use False Authority?

Accepted Answer

A naturopath (ND) claims to diagnose and treat complex psychiatric and neurological conditions (ADD/ADHD, depression, anxiety) via urine neurotransmitter testing, a practice outside standard naturopathic scope and unsupported by mainstream evidence for diagnosis. Likely motive: To position the ND as a primary diagnostic authority for serious mental health conditions, bypassing psychiatrists and creating a unique patient funnel.

Question 5

Does Josselson use Fear Mongering?

Accepted Answer

Links common gut issues to a terrifying cascade of severe systemic diseases (autoimmune, mental disorders, diabetes) to induce anxiety and justify expensive stool testing. Likely motive: To create a sense of urgency and fear that drives patients to purchase the 'Comprehensive Stool Analysis' and subsequent gut protocols.

Question 6

Does Josselson use False Dichotomy?

Accepted Answer

Frames conventional medicine as universally useless for recurring symptoms, implying that only the ND's 'natural' approach can solve the problem, ignoring the nuance of chronic disease management. Likely motive: To alienate patients from their primary care physicians and position the ND as the sole solution for 'unexplained' symptoms.

Question 7

Is the claim "Adrenal Testing (saliva cortisol) can diagnose 'adrenal imbalance' causing morning/even…" supported by medical literature?

Accepted Answer

High-quality evidence supports the use of salivary cortisol or cortisone as part of the diagnostic workup for true adrenal disorders such as adrenal insufficiency and Cushing syndrome, especially within structured dynamic testing protocols and defined cutoffs. Multiple observational and interventional studies, as summarized in reviews and guidelines, show that salivary cortisol or cortisone can be a useful, non‑invasive adjunct in diagnosing adrenal insufficiency when used with ACTH (cosyntropin) stimulation or in home waking sampling algorithms, with reported sensitivities and specificities often in the 80–90% range for adrenal insufficiency in appropriate contexts. There is also evidence that late‑night salivary cortisol is a validated first‑line screening test for Cushing syndrome in guideline‑type endocrine testing protocols. These data collectively support that salivary cortisol can reflect HPA axis function and be clinically useful for recognized adrenal pathologies when interpreted within evidence‑based algorithms, but not that it diagnoses a broad, non‑standard entity like “adrenal imbalance” responsible for multiple nonspecific symptoms. A systematic review dedicated specifically to the concept of “adrenal fatigue” concluded that there is no substantiation that adrenal fatigue/adrenal imbalance is an actual medical condition and that cortisol tests (including salivary ones) should not be used in clinical practice for examining fatigue or similar nonspecific states unless adrenal impairment is truly suspected. The review found no consistent correlation between the cortisol measures used in this context and the symptom cluster (fatigue, low energy, stress intolerance, etc.), and the commonly used salivary indices (cortisol awakening response, diurnal cortisol, etc.) did not reliably distinguish symptomatic individuals from controls. Established endocrine reviews emphasize that while salivary cortisol has emerging roles in diagnosing adrenal insufficiency and Cushing syndrome, random or diurnal salivary cortisol profiles alone are not reliable for diagnosing vague syndromes or broad symptom clusters, and morning salivary cortisol alone is not a robust diagnostic for adrenal insufficiency. Major clinical practice guidelines and reviews on adrenal insufficiency focus on recognized entities (primary, secondary, tertiary adrenal insufficiency, and Cushing syndrome) and do not endorse “adrenal imbalance/fatigue” as a diagnosis or recommend multi‑time‑point salivary cortisol panels to explain symptoms such as chronic fatigue, PMS, poor stress tolerance, low libido, weight gain, or chemical sensitivity. Overall, the claim that salivary cortisol can diagnose a catch‑all adrenal imbalance responsible for a wide range of symptoms is directly at odds with the systematic review evidence and with mainstream guideline‑based practice. The mainstream medical and endocrine position is that salivary cortisol testing is a validated, non‑invasive tool for specific, well‑defined adrenal disorders—primarily screening for Cushing syndrome with late‑night salivary cortisol and assisting in the diagnosis or monitoring of adrenal insufficiency when used in structured protocols with appropriate stimulation tests and validated cutoffs. However, major endocrine societies, systematic reviews, and guideline‑style documents do not recognize “adrenal fatigue” or a loosely defined “adrenal imbalance” as legitimate diagnoses, and they do not endorse the use of multitime‑point salivary cortisol panels to attribute broad, nonspecific complaints such as fatigue, susceptibility to infection, insomnia, PMS, chemical sensitivity, mood symptoms, allergies, blood sugar instability, low sex drive, or weight gain to subtle adrenal dysfunction. In standard practice, such symptoms prompt evaluation for recognized conditions (e.g., major depression, sleep disorders, thyroid disease, anemia, metabolic disorders, primary adrenal insufficiency, or Cushing syndrome) rather than diagnosis of adrenal imbalance by commercial saliva cortisol testing. Accordingly, mainstream practice accepts salivary cortisol only within evidence‑based pathways for true adrenal disease and explicitly considers adrenal fatigue/imbalance an unproven construct not supported by current evidence. Literature verdict: unsupported.

Question 8

Is the claim "Organic Acid Test (OAT) can diagnose intestinal yeast/bacteria overgrowth, vitamin/mine…" supported by medical literature?

Accepted Answer

Urinary organic acids testing is an established tool in mainstream medicine for specific, narrow indications, mainly screening for inborn errors of metabolism and certain mitochondrial or metabolic disorders, not for broad functional assessments of health. Large pediatric and metabolic texts describe organic acid analysis as part of the evaluation of unexplained metabolic acidosis, failure to thrive, or suspected inborn metabolic defects, where abnormal organic acids reflect specific enzymatic blocks rather than diffuse gut or wellness states. In intestinal failure and severe malnutrition, metabolic and micronutrient derangements can be reflected in various biochemical tests, but these chapters emphasize standard nutritional, biochemical, and clinical assessment—not OAT—as the basis for diagnosing intestinal pathology or malnutrition. Some functional-medicine sources propose that certain urinary organic acids may correlate with gut microbial activity, vitamin cofactor status, oxidative stress, or neurotransmitter metabolism, and these panels are marketed as providing an overview of metabolic function, but these uses are largely extrapolated from basic biochemistry rather than validated in large, prospective diagnostic studies. Mainstream gastroenterology and nutrition literature do not recognize commercial Organic Acid Tests as diagnostic tools for intestinal yeast or bacterial overgrowth. Evidence-based discussions of small intestinal bacterial overgrowth (SIBO) describe diagnosis by small-bowel aspirate culture or standardized breath tests and do not include urinary organic acid panels as accepted diagnostic methods. Similarly, in pediatric malnutrition and intestinal failure, core references focus on clinical assessment, anthropometrics, and standard blood-based micronutrient testing for vitamin and mineral deficiencies, not urine organic acid panels. The pediatric and general nutrition literature describes vitamin and mineral deficiency in terms of dietary intake, absorption issues (including bacterial competition for B12 in overgrowth states), and serum or functional biomarkers, not OAT-type panels. There is no high-quality evidence (large RCTs, systematic reviews, or major guidelines) supporting OAT as a reliable test for intestinal yeast/bacterial overgrowth, comprehensive micronutrient status, or clinically relevant oxidative stress and neurotransmitter levels, and several critical reviews note that reference ranges and diagnostic cutoffs for these commercial tests are often not validated in independent peer-reviewed studies. In mainstream practice, urinary neurotransmitter metabolites (such as 5-HIAA or catecholamine metabolites) are used in very specific diagnostic contexts—for example, to evaluate carcinoid tumors or catecholamine-secreting tumors—but not as a generalized assessment of brain neurotransmitter status or overall health, and this limited, disease-focused use is quite different from the broad functional claims of OAT panels. The mainstream medical position is that urinary organic acid analysis is a specialized tool used primarily for diagnosing inborn errors of metabolism and certain rare metabolic disorders, generally in hospital or specialized laboratory settings, and is not validated or recommended as a comprehensive metabolic snapshot of overall health. For intestinal yeast or bacterial overgrowth, accepted diagnostic approaches include small-bowel aspirate culture and standardized breath testing; urinary organic acids are not part of guideline-based workups for SIBO, fungal overgrowth, or irritable bowel syndrome. For vitamin and mineral deficiencies, mainstream practice relies on dietary assessment, clinical examination, and serum or functional blood-based biomarkers (e.g., serum B12, ferritin, 25-hydroxyvitamin D), occasionally supported by targeted tests based on specific conditions such as bacterial competition for B12 in overgrowth states. Oxidative stress and neurotransmitter status are complex, multi-compartment phenomena for which there is no guideline-endorsed single laboratory test; while certain urinary metabolites can indicate specific pathologies (e.g., 5-HIAA for serotonin-secreting tumors), these are not used to characterize general neurotransmitter balance or systemic oxidative stress. Major gastroenterology, nutrition, and metabolic guidelines do not recommend commercial OAT panels for routine diagnosis or management of gut disorders, micronutrient status, oxidative stress, or mental health conditions. Literature verdict: unsupported.

Advertised	Verdict
Listed service Thyroid Support	Outside scope
Listed service Depression	Outside scope
Listed service Behavioral problems (including ADD/ADHD)	Outside scope
Listed service PMS and hormonal imbalance	Outside scope

Josselson alias Dr. Neurotransmitter Nonsense

Score breakdown

Key findings

Claims & evidence

Manipulation

Borrowed authority & guest funnel

Host self-funnel

Commerce & grift map

Thorne

Pure Encapsulations

Supplements pitched

Labs pitched

How the money flows

Store links detected

Sponsors and advertisers

Credentials & scope

Permitted scope vs advertised

What this license permits

Scope comparison mirror

When the service is also outside their license

Validated associated properties

Analyzed

Tip the jar

Fight disinformation

Log a new mention

Reply snippets

Recent mentions (this doc)

Nudge the Doc Bro

Pick a contact address

What gets sent

Know someone who can help?

Who should we nudge?

What gets sent

Whambulance

Public challenge log

File a challenge

Citations